Zhihong Cheng
- Cancer Research top 10%
- Oncology top 10%
- Physiology top 10%
-
- RNA modifications and cancer 3
- Signaling Pathways in Disease 3
- RNA and protein synthesis mechanisms 3
- Glycosylation and Glycoproteins Research 2
- Epigenetics and DNA Methylation 2
- Hepatology top 10%
-
- Cardiac Fibrosis and Remodeling 3
-
- Galectins and Cancer Biology 3
-
- Bone Tissue Engineering Materials 2
- Co-authors
- Hua DongZhizhi WangFeng CongThomas R. HindsYue ZhangWenqing XuGregory A. MichaudErkang Fan
- Cited by
- Cancer ResearchOncologyPhysiology
- Journals
- Frontiers in Pharmacology (2 papers)Experimental and Molecular Pathology (2 papers)Frontiers in Microbiology (1 paper)
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Zhihong Cheng
25 papers receiving 876 citations
Peers
Comparison fields: 5 of 89
- Cancer Research 194
- Oncology 285
- Physiology 47
- Molecular Biology 556
- Hepatology 52
Countries citing papers authored by Zhihong Cheng
This map shows the geographic impact of Zhihong Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhihong Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhihong Cheng more than expected).
Fields of papers citing papers by Zhihong Cheng
This network shows the impact of papers produced by Zhihong Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhihong Cheng. The network helps show where Zhihong Cheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhihong Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2022 | 13 | |
| 3 | 2021 | 8 | |
| 4 | 2021 | 0 | |
| 5 | 2021 | 8 | |
| 6 | 2020 | 13 | |
| 7 | 2014 | 9 | |
| 8 | 2013 | 41 | |
| 9 | 2013 | 17 | |
| 10 | 2012 | 30 | |
| 11 | 2012 | 206 | |
| 12 | 2012 | 11 | |
| 13 | 2011 | 98 | |
| 14 | 2011 | 79 | |
| 15 | 2010 | 1 | |
| 16 | 2009 | 51 | |
| 17 | 2009 | 107 | |
| 18 | Chemical Constituents in the Tubers of Ophiopogon japonicus | 2005 | 1 |
| 19 | 2004 | 31 | |
| 20 | 2004 | 91 |
About Zhihong Cheng
Zhihong Cheng is a scholar working on Cancer Research, Oncology and Immunology, having authored 26 papers that have together received 888 indexed citations. Recurring topics across this work include RNA modifications and cancer (3 papers), Cardiac Fibrosis and Remodeling (3 papers), Signaling Pathways in Disease (3 papers), RNA and protein synthesis mechanisms (3 papers), Galectins and Cancer Biology (3 papers), Glycosylation and Glycoproteins Research (2 papers), Bone Tissue Engineering Materials (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (194 citations), Oncology (285 citations) and Physiology (47 citations). Zhihong Cheng has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Hua Dong, Zhizhi Wang, Feng Cong, Thomas R. Hinds, Yue Zhang, Wenqing Xu, Gregory A. Michaud, Erkang Fan, Haiwei Song and Zhaohui Huang. Their work appears in journals such as Frontiers in Pharmacology, Experimental and Molecular Pathology, Frontiers in Microbiology, Materials & Design and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.